Copyright
©The Author(s) 2021.
World J Gastroenterol. Sep 28, 2021; 27(36): 6093-6109
Published online Sep 28, 2021. doi: 10.3748/wjg.v27.i36.6093
Published online Sep 28, 2021. doi: 10.3748/wjg.v27.i36.6093
Figure 4 Representative agarose gel picture of polymerase chain reaction amplification (A) and restriction fragment length polymorphism using BstN1 (B) for KRAS codon 12.
The arrow represents the 157 bp amplicon and M denotes the DNA marker (50 bp). Lane M represents a DNA marker (50 bp). Lanes 2, 4, 7, 8, and 10 represent the mutant band (undigested) of 157 bp. Lane 1, 3, 6, and 9 represent the wild band (digested) of 128 bp. U represents the undigested band used as mutant control.
- Citation: Rah B, Banday MA, Bhat GR, Shah OJ, Jeelani H, Kawoosa F, Yousuf T, Afroze D. Evaluation of biomarkers, genetic mutations, and epigenetic modifications in early diagnosis of pancreatic cancer. World J Gastroenterol 2021; 27(36): 6093-6109
- URL: https://www.wjgnet.com/1007-9327/full/v27/i36/6093.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i36.6093